326 related articles for article (PubMed ID: 28126558)
1. Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug.
van der Vossen AC; van der Velde I; Smeets OS; Postma DJ; Eckhardt M; Vermes A; Koch BC; Vulto AG; Hanff LM
Eur J Pharm Sci; 2017 Mar; 100():205-210. PubMed ID: 28126558
[TBL] [Abstract][Full Text] [Related]
2. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
[TBL] [Abstract][Full Text] [Related]
3. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
Cirri M; Mura P; Mora PC
Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
[TBL] [Abstract][Full Text] [Related]
4. Rational design and development of a stable liquid formulation of riluzole and its pharmacokinetic evaluation after oral and IV administrations in rats.
Sarkar M; Grossman RG; Toups EG; Chow DS
Eur J Pharm Sci; 2018 Dec; 125():1-10. PubMed ID: 30201516
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture.
Joshi HN; Tejwani RW; Davidovich M; Sahasrabudhe VP; Jemal M; Bathala MS; Varia SA; Serajuddin AT
Int J Pharm; 2004 Jan; 269(1):251-8. PubMed ID: 14698596
[TBL] [Abstract][Full Text] [Related]
6. Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.
Shamma R; Elkasabgy N
Drug Deliv; 2016; 23(2):489-99. PubMed ID: 24892631
[TBL] [Abstract][Full Text] [Related]
7. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug.
Li P; Hynes SR; Haefele TF; Pudipeddi M; Royce AE; Serajuddin AT
J Pharm Sci; 2009 May; 98(5):1750-64. PubMed ID: 18781639
[TBL] [Abstract][Full Text] [Related]
8. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system.
Dannenfelser RM; He H; Joshi Y; Bateman S; Serajuddin AT
J Pharm Sci; 2004 May; 93(5):1165-75. PubMed ID: 15067693
[TBL] [Abstract][Full Text] [Related]
9. A new formulation concept for drugs with poor water solubility for parenteral application.
Jürgens K; Müller BW
Pharmazie; 2005 Sep; 60(9):665-70. PubMed ID: 16222865
[TBL] [Abstract][Full Text] [Related]
10. Development of a liquid formulation of poorly water-soluble isosteviol sodium using the co-solvent technology.
Lai W; Kang Q; Zou C; Li Q; Sun H; Tan W
Pharm Dev Technol; 2017 Mar; 22(2):275-282. PubMed ID: 27557399
[TBL] [Abstract][Full Text] [Related]
11. Aqueous solvent system for the solubilization of azole compounds.
Kovács K; Stampf G; Klebovich I; Antal I; Ludányi K
Eur J Pharm Sci; 2009 Feb; 36(2-3):352-8. PubMed ID: 19022381
[TBL] [Abstract][Full Text] [Related]
12. Effect of hydroxypropyl beta-cyclodextrin on drug solubility in water-propylene glycol mixtures.
Chang RK; Shojaei AH
Drug Dev Ind Pharm; 2004 Mar; 30(3):297-302. PubMed ID: 15109029
[TBL] [Abstract][Full Text] [Related]
13. Oral drug delivery strategies for development of poorly water soluble drugs in paediatric patient population.
Salunke S; O'Brien F; Cheng Thiam Tan D; Harris D; Math MC; Ariën T; Klein S; Timpe C;
Adv Drug Deliv Rev; 2022 Nov; 190():114507. PubMed ID: 36049580
[TBL] [Abstract][Full Text] [Related]
14. Development and in vitro/in vivo evaluation of a novel benznidazole liquid dosage form using a quality-by-design approach.
Santos Souza HF; Real D; Leonardi D; Rocha SC; Alonso V; Serra E; Silber AM; Salomon CJ
Trop Med Int Health; 2017 Dec; 22(12):1514-1522. PubMed ID: 28944986
[TBL] [Abstract][Full Text] [Related]
15. A novel intravenous vehicle for preclinical cardiovascular screening of small molecule drug candidates in rat.
Banfor PN; Gintant GA; Lipari JM; Zocharski PD
J Pharmacol Toxicol Methods; 2016; 82():62-67. PubMed ID: 27432021
[TBL] [Abstract][Full Text] [Related]
16. Development of oral liquid dosage forms of acetazolamide.
Parasrampuria J; Das Gupta V
J Pharm Sci; 1990 Sep; 79(9):835-6. PubMed ID: 2273470
[TBL] [Abstract][Full Text] [Related]
17. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
Chandrasekaran P; Kandasamy R
AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
[TBL] [Abstract][Full Text] [Related]
18. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
Hegge AB; Másson M; Kristensen S; Tønnesen HH
Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
[TBL] [Abstract][Full Text] [Related]
19. Flexible New Dosage Forms Containing Carvedilol for the Treatment of Patients with Cardiovascular Disorders: Development, Stability, Palatability, and Microbiological Studies.
Operto MA; Maggio R; Leonardi D; Vignaduzzo S
AAPS PharmSciTech; 2023 Jul; 24(6):159. PubMed ID: 37498506
[TBL] [Abstract][Full Text] [Related]
20. The effect of glycerol, propylene glycol and polyethylene glycol 400 on the partition coefficient of benzophenone-3 (oxybenzone).
Mbah CJ
Pharmazie; 2007 Jan; 62(1):38-40. PubMed ID: 17294811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
